Proteins, unlike DNA and RNA, cannot be amplified. And without accurate, high-sensitivity proteomic profiling, critical diagnostic and therapeutic opportunities are missed. Existing technologies are not built to handle the scale of modern biopsy methods, liquid microsampling, or single-cell investigations.
MixedLCmediA’s PLOT-based chromatography platform is designed specifically to address this sensitivity gap.